Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of BAY 85-8501 in Non-Cystic Fibrosis Bronchiectasis
2012-004491-18Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PHP-303 in bronchiectasis, sponsored by Bayer. Started Dec 2012; status: completed.
02
Drugs
PHP-303
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2012-004491-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004491-18.